The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation

Journal of Immunology

Volumn 167, Issue 8, 2001, Pages 4518-4526

  Jones, H P ^a   Hodge, L M ^a   Fujihashi, K ^a   Kiyono, H ^a   McGhee, J R ^a   Simecka, J W ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHOLERA TOXIN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLUENZA VACCINATION; INTERFERON PRODUCTION; LUNG INFILTRATE; MOUSE; NONHUMAN; NOSE MUCOSA; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; TH1 CELL; TH2 CELL;

EID: 0035887789     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.8.4518     Document Type: Article

References (78)

1. Antibody responses after Sendai virus infection and their role in upper and lower respiratory tract disease in rats
2. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus
3. Comparison of protective effects of serum antibody on respiratory and systemic infection of Sendai virus in mice
4. Passive transfer of local immunity to influenza virus infection by IgA antibody
5. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity
6. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortment vaccine virus in adult volunteers: Role of local antibody in resistance to infection with vaccine virus
7. Intracellular neutralization of virus by immunoglobulin A antibodies
8. Intracellular neutralization of influenza virus by IgA anti-HA monoclonal antibodies
9. Intracellular interaction between IgA antibody and viral nucleoprotein
10. Roles of innate and adaptive immunity in respiratory mycoplasmosis
11. Risk factors for allergy
12. Asthma: An inflammatory disease
13. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years
14. Respiratory viral and Mycoplasma infections in patients hospitalized for acute asthma
15. IgA levels, bacterial carrier rate, and the development of bronchial asthma in children
16. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma
17. The relevance of allergen exposure to the development of asthma in childhood
18. A retrospective study of the relationship between childhood asthma and respiratory infection during gestation
19. Involuntary smoking and asthma
20. Differences in incidence of reported asthma related to age in men and women: A retrospective analysis of the data of the European respiratory health survey
21. Smoking and airway hyperresponsiveness especially in the presence of blood eosinophilia increase the risk to develop respiratory symptoms: A 25-year follow-up study in the general adult population
22. Protection against airsacculitis with sequential systemic and local immunization of chickens using killed Mycoplasma gallisepticum bacterin with carrageenan adjuvant
23. Murine model for evaluation of protective immunity to influenza virus
24. Mucosal immunization with a subunit respiratory syncytial virus vaccine in mice
25. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit
26. Comparison of IgA versus 1gG monoclonal antibodies for passive immunization of the murine respiratory tract
27. Rapid recovery in mice after combined nasal/oral immunization with killed respiratory syncytial virus
28. Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization
29. Mucosally-induced IgE-associated inflammation in the respiratory tract
30. Immunological aspects of allergic asthma
31. Interactions of mycoplasmas with B cells: Antibody production and nonspecific effects
32. Specific and nonspecific antibody responses in different segments of the respiratory tract in rats infected with Mycoplasma pulmonis
33. TH1 and TH2: Different patterns of lymphokine secretion lead to different functional properties
34. Functions of T-cell subsets and cytokines in mycobacterial infections
35. Increased resistance to mycobacterial infection in the absence of interleukin-10
36. Multiple defects of immune cell function in mice with disrupted interferon-γ genes
37. Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues
38. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin
39. Mucosal immunity of the gastrointestinal tract and oral tolerance
40. Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody
41. Interleukin I2 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice
42. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells
43. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
44. T cells and eosinophils in the pathogenesis of asthma
45. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma
46. Respiratory synctial virus infection in BALB/c mice previously immunized with Formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern
47. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA)
48. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection
49. Shifts in interleukin-4 and interferon-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis
50. Regulation of the development of type 2 T-helper cells in allergy
51. Differential regulation of murine T lymphocyte subsets
52. Use of gut lavage fluid to measure intestinal humoral immunity, GI bleeding and protein losses in Sierra Leonean children
53. Dendritic cells are present in the alveolar region of lungs from specific pathogen-free rats
54. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase
55. Isolation and fractionation of mononuclear cell populations
56. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
57. Gene expression and production of tumor necrosis factor α, interleukin 1, interleukin 6, and γ interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease
58. New derivative of pMUS for quantitation of mouse IL-12 (p35, p40), IL-10 and IFN-γ-R mRNAs
59. β-chemokines are produced in lungs of mice with mycoplasma respiratory disease
60. Human monocyte chemoattractant protein-1 (MCP-1)
61. Biology of the RANTES/SIS cytokine family
62. Properties of the novel proinflammatory supergene "intercrine" cytokine family
63. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells
64. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses
65. T helper 1 and T helper 2 cells respond differentially to chemokines
66. Murine cutaneous leishmaniasis: Susceptibility correlates with differential expansion of helper T-cell subsets
67. IL-4 induces a Th2 response in Leishmania major-infected mice
68. Site of antigen delivery can influence T cell priming: Pulmonary environment promotes preferential Th2-type differentiation
69. Cytokine- and Ig-producing T cells in mucosal effector tissues: Analysis of IL-5 and IFN-γ-producing T cells, T cell receptor expression, and IgA plasma cells from mouse salivary gland-associated tissues
70. Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse
71. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4
72. Similar subclass antibody responses after intranasal immunization with UV-inactivated RSV mixed with cholera toxin or live RSV
73. Cholera toxin as a mucosal adjuvant for respiratory antibody responses in mice
74. Differential CC chemokine-induced enhancement of T helper cell cytokine production
75. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
76. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models
77. Chemokine expression in Th1 cell-induced lung injury: Prominence of 1FN-γ-inducible chemokines
78. + T cell depletion